⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22126696 | 0.79 | CA1 (0.30) | — | |
| SCHEMBL114743 | 0.74 | — | — | |
| SCHEMBL2058153 | 0.74 | — | — | |
| SCHEMBL19665461 | 0.74 | CA1 (0.30) | — | |
| SCHEMBL631967 | 0.74 | — | — | |
| SCHEMBL2057215 | 0.74 | ALDH1A1 (0.35) | — | |
| SCHEMBL36993 | 0.74 | CA1 (0.30) | — | |
| SCHEMBL6686768 | 0.74 | CA1 (0.30) | — | |
| SCHEMBL8821747 | 0.73 | — | — | |
| SCHEMBL630910 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109206441-B | Purification method of everolimus | 正大天晴药业集团股份有限公司 | 2022-05-20 | — | — | CN | claimed |
| EP-3206695-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | The Board of Trustees of the University of Illionis (US) | 2017-08-23 | — | — | EP | claimed |
| US-20170233427-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2017-08-17 | — | — | US | claimed |
| WO-2016061437-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-04-21 | — | — | WO | claimed |
| CN-117558982-A | Electrolyte for improving multiplying power performance and lithium ion battery | 合肥国轩高科动力能源有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-109206441-B | Purification method of everolimus | 正大天晴药业集团股份有限公司 | 2022-05-20 | — | — | CN | disclosed |
| EP-3929203-A1 | DERIVATIVES OF AMPHOTERICIN B | Sfunga Therapeutics, Inc. (US) | 2021-12-29 | — | — | EP | disclosed |
| EP-3283171-B1 | DERIVATIVES OF AMPHOTERICIN B | SFUNGA THERAPEUTICS INC (US) | 2021-05-26 | — | — | EP | disclosed |
| US-10882883-B2 | Derivatives of amphotericin B | SFUNGA THERAPEUTICS, INC. (US) | 2021-01-05 | — | — | US | disclosed |
| US-20200262858-A1 | DERIVATIVES OF AMPHOTERICIN B | ELION THERAPEUTICS, INC. | 2020-08-20 | — | — | US | disclosed |
| US-10683318-B2 | Scalable synthesis of reduced toxicity derivative of amphotericin B | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2020-06-16 | — | — | US | disclosed |
| US-10597420-B2 | Derivatives of amphotericin B | SFUNGA THERAPEUTICS, INC. (US) | 2020-03-24 | — | — | US | disclosed |
| EP-3206695-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | The Board of Trustees of the University of Illionis (US) | 2017-08-23 | — | — | EP | disclosed |
| US-20170233427-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2017-08-17 | — | — | US | disclosed |
| WO-2016168568-A1 | DERIVATIVES OF AMPHOTERICIN B | Revolution Medicines, Inc. (US) | 2016-10-20 | — | — | WO | disclosed |
| US-20160304548-A1 | Derivatives of Amphotericin B | ELION THERAPEUTICS, INC. | 2016-10-20 | — | — | US | disclosed |
| WO-2016061437-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-04-21 | — | — | WO | disclosed |
| EP-0985674-B1 | ORGANIC COMPOUNDS CONTAINING SILICON OR GERMANIUM, TRANSITION METAL COMPLEXES, CATALYST FOR ALPHA-OLEFIN POLYMERIZATION, AND PROCESSES FOR PRODUCING ALPHA-OLEFIN POLYMERS | MITSUBISHI CHEM CORP (JP) | 2003-04-23 | — | — | EP | disclosed |
| US-6255515-B1 | COORDINATION POLYMERIZATION CATALYSTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-07-03 | — | — | US | disclosed |
| EP-0985674-A1 | ORGANIC COMPOUNDS CONTAINING SILICON OR GERMANIUM, TRANSITION METAL COMPLEXES, CATALYST FOR $g(a)-OLEFIN POLYMERIZATION, AND PROCESSES FOR PRODUCING $g(a)-OLEFIN POLYMERS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-03-15 | — | — | EP | disclosed |